Support for International Cooperation in Systems Cancer in Neo-dimension

• Project Area: Conquering cancer through neo-dimensional systems understanding
• Project/Area Number: 15K21741
• Research Category: Grant-in-Aid for Scientific Research on Innovative Areas (Research in a proposed research area)
• Allocation Type: Multi-year Fund
• Review Section: Complex systems
• Research Institution: Tokyo Medical and Dental University (2020-2021); The University of Tokyo (2015-2019)
• Principal Investigator: Miyano Satoru 東京医科歯科大学, M&Dデータ科学センター, 特任教授 (50128104)
• Project Period (FY): 2015-11-06 – 2022-03-31
• Project Status: Completed (Fiscal Year 2021)
• Budget Amount: ¥62,140,000 (Direct Cost: ¥47,800,000、Indirect Cost: ¥14,340,000); Fiscal Year 2019: ¥14,820,000 (Direct Cost: ¥11,400,000、Indirect Cost: ¥3,420,000); Fiscal Year 2018: ¥14,820,000 (Direct Cost: ¥11,400,000、Indirect Cost: ¥3,420,000); Fiscal Year 2017: ¥14,820,000 (Direct Cost: ¥11,400,000、Indirect Cost: ¥3,420,000); Fiscal Year 2016: ¥14,820,000 (Direct Cost: ¥11,400,000、Indirect Cost: ¥3,420,000); Fiscal Year 2015: ¥2,860,000 (Direct Cost: ¥2,200,000、Indirect Cost: ¥660,000)
• Keywords: がん / システム生物学 / ゲノム科学 / バイオインフォマティクス / 人工知能

Outline of Final Research Achievements

The starting point was to investigate the international network of the members and share international trends with international researchers. Activities were carried out by fusing human interactions (including networks) with the use of supercomputers and artificial intelligence. We mutually exchanged researchers and held symposiums for international cooperation with researchers from the United States, Sweden, the United Kingdom, Thailand, South Korea, Finland, Mexico, Germany, Denmark, etc. As a result, we have produced world-class research results and solidified international cooperation.

Academic Significance and Societal Importance of the Research Achievements

本国際連携支援プロジェクトにより、がん研究のみならずELSI研究の世界トップランナーとの強い絆ができた。特にがんゲノミクス研究では、スーパーコンピュータを活用した国際共同研究が高いレベルで行われ顕著な成果が得られ大きな学術的意義があった。また、学生を含む派遣・受入れ交流は、次世代の研究者の育成に大きく貢献したことは人材育成の観点から社会的意義があったと考える。

Research Products

• [Int'l Joint Research] カロリンスカ研究所(スウェーデン)
• [Int'l Joint Research] Sanger Institute(英国)
• [Int'l Joint Research] Ichahn School of Medicine at Mount Sinai/Harvard Medical School(米国)
• [Int'l Joint Research] フンボルト大学(ドイツ)
• [Int'l Joint Research] Seoul National University(韓国)
• [Int'l Joint Research] カロリンスカ研究所(スウェーデン)
• [Int'l Joint Research] Sanger Institute(英国)
• [Int'l Joint Research] Icahn School of Medicine at Mount Sinai/Harvard Medical School(米国)
• [Int'l Joint Research] フンボルト大学(ドイツ)
• [Int'l Joint Research] Seoul National University/National Cancer Center(韓国)
• [Int'l Joint Research] Sanger Institute(英国)
• [Int'l Joint Research] Icahn School of Medicine at Mount Sinai/Harvard Medical School(米国)
• [Int'l Joint Research] カロリンスカ研究所(スウェーデン)
• [Int'l Joint Research] フンボルト大学(ドイツ)
• [Int'l Joint Research] Seoul National University/National Cancer Center(韓国)
• [Int'l Joint Research]
• [Int'l Joint Research] ミシガン大学(米国)
• [Int'l Joint Research] ヘルシンキ大学/カロリンスカ研究所(スウェーデン)
• [Int'l Joint Research] Sanger Institute(英国)
• [Int'l Joint Research] チュラロンコン大学(タイ)
• [Int'l Joint Research] The University of Hong Kong/The Chinese University of Hong Kong/City University of Honk Kong(中国)
• [Int'l Joint Research]
• [Int'l Joint Research] シカゴ大学/Harvard Medical School/Ichahn School of Medicine at Mount Sinai(米国)
• [Int'l Joint Research] カロリンスカ研究所(スウェーデン)
• [Int'l Joint Research] チュラロンコン大学(タイ)
• [Int'l Joint Research] The Wellcome Trust Sanger Institute(英国)
• [Int'l Joint Research] University of Ulsan College of Medicine/Seoul National University(韓国)
• [Int'l Joint Research] Chulalongkorn University(タイ)
• [Int'l Joint Research] The University of Chicago/Oklahoma University/Cleveland Clinic(米国)
• [Int'l Joint Research] Seoul National University(韓国)
• [Int'l Joint Research] Ontario Institute for Cancer Research(カナダ)
• [Int'l Joint Research] The Sanger Institute(英国)
• [Int'l Joint Research] The University of Chicago/IBM/Oklahoma University(米国)
• [Int'l Joint Research] Chinese Academy of Sciences(China)
• [Int'l Joint Research] Thammasat University(Thailand)
• [Int'l Joint Research] The University of Tampa(Finland)
• [Int'l Joint Research] Seoul National University(韓国)
• [Journal Article] The landscape of genetic aberrations in myxofibrosarcoma (2022)
  • Author(s): Takeuchi Y, Yoshida K, Halik A, Kunitz A, Suzuki H, Kakiuchi N, Shiozawa Y, Yokoyama A, Inoue Y, Hirano T, Yoshizato T, Aoki K, Fujii Y, Nannya Y, Makishima H, Pfitzner BM, Bullinger L, Hirata M, Jinnouchi K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Okamoto T, Haga H, Ogawa S, Damm F.
  • Journal Title: Int J Cancer Volume: - Issue: 4 Pages: 565-577
  • DOI: 10.1002/ijc.34051
  • Peer Reviewed / Int'l Joint Research
• [Journal Article] Prediction of drug candidates for clear cell renal cell carcinoma using a systems biology-based drug repositioning approach (2022)
  • Author(s): Li X, Shong K, Kim W, Yuan M, Yang H, Sato Y, Kume H, Ogawa S, Turkez H, Shoaie S, Boren J, Nielsen J, Uhlen M, Zhang C, Mardinoglu A
  • Journal Title: EBioMedicine Volume: - Pages: 103963-103963
  • DOI: 10.1016/j.ebiom.2022.103963
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Pseudouridine-modified tRNA fragments repress aberrant protein synthesis and predict leukaemic progression in myelodysplastic syndrome (2022)
  • Author(s): Guzzi N, Muthukumar S, Todisco G, Ngoc PCT, Madej M, Munita R, Fazio S, Ekström S, Mortera-Blanco T, Jansson M, Nannya Y, Cazzola M, Ogawa S, Malcovati L, Hellström-Lindberg E, Dimitriou M, Bellodi C
  • Journal Title: Nat Cell Biol Volume: 24(3) Issue: 3 Pages: 299-306
  • DOI: 10.1038/s41556-022-00852-9
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Aged healthy mice acquire clonal hematopoiesis mutations (2022)
  • Author(s): Chin DWL, Yoshizato T, Virding Culleton S, Grasso F, Barbachowska M, Ogawa S, Jacobsen SEW, Woll PS
  • Journal Title: Blood Volume: 139(4) Issue: 4 Pages: 629-634
  • DOI: 10.1182/blood.2021014235
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Mapping the human genetic architecture of COVID-19 (2022)
  • Author(s): COVID-19 Host Genetics Initiative
  • Journal Title: Nature Volume: 600(7889) Issue: 7889 Pages: 472-477
  • DOI: 10.1038/s41586-021-03767-x
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Patient-specific MDS-RS iPSCs define the mis-spliced transcript repertoire and chromatin landscape of SF3B1-mutant HSPCs (2022)
  • Author(s): Asimomitis G, Deslauriers AG, Kotini AG, Bernard E, Esposito D, Olszewska M, Spyrou N, Arango Ossa J, Mortera-Blanco T, Koche R, Nannya Y, Malcovati L, Ogawa S, Cazzola M, Aaronson SA, Hellström-Lindberg E, Papaemmanuil E, Papapetrou EP
  • Journal Title: Blood Adv Volume: 6(10) Pages: 2992-3005
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Molecular classification and diagnostics of upper urinary tract urothelial carcinoma (2021)
  • Author(s): 藤井陽一、佐藤悠佑、鈴木啓道、川合剛人、森川鉄平、白石友一、中川徹、久米春喜、小川誠司他
  • Journal Title: Cancer Cell Volume: 39 Issue: 6 Pages: 793-809
  • DOI: 10.1016/j.ccell.2021.05.008
  • NAID: 120007089270
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Stratification of patients with clear cell renal cell carcinoma to facilitate drug repositioning (2021)
  • Author(s): Li X, Kim W, Juszczak K, Arif M, Sato Y, Kume H, Ogawa S, Turkez H, Boren J, Nielsen J, Uhlen M, Zhang C, Mardinoglu A
  • Journal Title: iScience Volume: 24(7) Issue: 7 Pages: 102722-102722
  • DOI: 10.1016/j.isci.2021.102722
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Clonal evolution and clinical implications of genetic abnormalities in blastic transformation of chronic myeloid leukaemia. (2021)
  • Author(s): Ochi Y, Yoshida K, Huang YJ, Kuo MC, Nannya Y, Sasaki K, Mitani K, et al.
  • Journal Title: Nat comm Volume: 12 Issue: 1 Pages: 2833-2833
  • DOI: 10.1038/s41467-021-23097-w
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (2021)
  • Author(s): Bernard E, Nannya Y, Hasserjian RP, Devlin SM, Follo MY, Thol F, Pinheiro RF, Schanz J, T, Polprasert C, Bennett JM, Klimek VM, Savona MR, Belickova M, Ganster C, Palomo L, Sanz G, Ades L, Della Porta MG, Elias HK, Smith AG, Werner Y, Patel M, Viale A, Vanness K, Neuberg DS, Stevenson KE, Ogawa S, Papaemmanuil E
  • Journal Title: Nat Med Volume: 27(5) Issue: 5 Pages: 927-927
  • DOI: 10.1038/s41591-021-01367-w
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Somatic mutations in lymphocytes in patients with immune-mediated aplastic anemia (2021)
  • Author(s): Lundgren Sofie、Kernen Mikko A. I.、Kankainen Matti、Huuhtanen Jani、Walldin Gunilla、Kerr Cassandra M.、Clemente Michael、Ebeling Freja、Rajala Hanna、Br?ck Oscar、L?hdesm?ki Harri、Hannula Sari、Hannunen Tiina、Ellonen Pekka、Young Neal S.、Ogawa Seishi、Maciejewski Jaroslaw P.、Hellstr?m-Lindberg Eva、Mustjoki Satu
  • Journal Title: Leukemia Volume: 35 Issue: 5 Pages: 1365-1379
  • DOI: 10.1038/s41375-021-01231-3
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial (2021)
  • Author(s): Hoyer K, Hablesreiter R, Inoue Y, Yoshida K, Briest F, Christen F, Kakiuchi N, Yoshizato T, Shiozawa Y, Shiraishi Y, Striefler JK, Bischoff S, Lohneis P, Putter H, Blau O, Keilholz U, Bullinger L, Pelzer U, Hummel M, Riess H, Ogawa S, Sinn M, Damm F
  • Journal Title: EBioMedicine Volume: 66 Pages: 103327-103327
  • DOI: 10.1016/j.ebiom.2021.103327
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Clonal expansion in non-cancer tissues (2021)
  • Author(s): Kakiuchi Nobuyuki、Ogawa Seishi
  • Journal Title: Nature Reviews Cancer Volume: 21 Issue: 4 Pages: 239-256
  • DOI: 10.1038/s41568-021-00335-3
  • Peer Reviewed / Open Access
• [Journal Article] Discovery of Functional Alternatively Spliced PKM Transcripts in Human Cancers (2021)
  • Author(s): Li X, Kim W, Arif M, Gao C, Hober A, Kotol D, Strandberg L, Forsström B, Sivertsson Å, Oksvold P, Turkez H, Grøtli M, Sato Y, Kume H, Ogawa S, Boren J, Nielsen J, Uhlen M, Zhang C, Mardinoglu A
  • Journal Title: Cancers (Basel) Volume: 13(2) Issue: 2 Pages: 348-348
  • DOI: 10.3390/cancers13020348
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas. Leuk Lymphoma (2021)
  • Author(s): Polprasert C, Takeuchi Y, Makishima H, Wudhikarn K, Kakiuchi N, Tangnuntachai N, Assanasen T, Sitthi W, Muhamad H, Lawasut P, Kongkiatkamon S, Bunworasate U, Izutsu K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Ogawa S, Yoshida K, Rojnuckarin P
  • Journal Title: Leuk Lymphoma Volume: 62(1) Issue: 1 Pages: 95-103
  • DOI: 10.1080/10428194.2020.1821011
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Co-mutation pattern, clonal hierarchy, and clone size concur to determine disease phenotype of SRSF2P95-mutated neoplasms (2020)
  • Author(s): Todisco Gabriele、Ogawa Seishi et al.
  • Journal Title: Leukemia Volume: - Issue: 8 Pages: 2371-2381
  • DOI: 10.1038/s41375-020-01106-z
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Two aldehyde clearance systems are essential to prevent lethal formaldehyde accumulation in mice and humans. (2020)
  • Author(s): Dingler FA†, Wang M†, Mu A† (Co-first), ....Takata M, Patel KJ.
  • Journal Title: Mol Cell Volume: 80 Issue: 6 Pages: 996-1012
  • DOI: 10.1016/j.molcel.2020.10.012
  • NAID: 120006951779
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Journal Article] Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes (2020)
  • Author(s): Bernard E, Nannya Y, Hasserjian RP, Ogawa S, Papaemmanuil E
  • Journal Title: Nat Med Volume: 26(10) Issue: 10 Pages: 1549-1556
  • DOI: 10.1038/s41591-020-1008-z
  • Peer Reviewed / Open Access / Int'l Joint Research
• [Presentation] Cancer mutations in normal tissues (2021)
  • Author(s): Seishi Ogawa
  • Organizer: The 1st International Symposium of CCII-Bioinformatics and its application to cancer and other diseases
  • Int'l Joint Research
• [Presentation] Clonal Expansion in Apparently Normal Tissues (2021)
  • Author(s): Seishi Ogawa
  • Organizer: JCA-AACR Precision Cancer Medicine International Conference
  • Int'l Joint Research
• [Presentation] Inflammation (2021)
  • Author(s): Seishi Ogawa
  • Organizer: AACR-JCA Joint Session explores tumor evolution
  • Int'l Joint Research
• [Presentation] Important Issues for Realizing AI Hospital : from cancer genomic medicine (2021)
  • Author(s): Satoru Miyano
  • Organizer: German Centre for Research Innovation Workshop (Online)
  • Int'l Joint Research / Invited
• [Presentation] Network Approaches to Drug Target/Resistance with Supercomputers (2021)
  • Author(s): Satoru Miyano
  • Organizer: 第80回日本癌学会学術総会Symposia 20: Drug discovery and diagnosis enhanced with AI
  • Int'l Joint Research / Invited
• [Presentation] Challenges to Personalized Medicine by AI and Big Data - Genomes to Networks (2021)
  • Author(s): Satoru Miyano
  • Organizer: 第62回日本神経学会学術大会Neuroscience Frontier Symposium 02 “Frontiers of neuroscience and medicine accelerated by big data and AI”
  • Int'l Joint Research / Invited
• [Presentation] がんゲノム医療と人工知能 (2021)
  • Author(s): 宮野 悟
  • Organizer: 第59回日本癌治療学会学術集会会長企画シンポジウム「AI oncology の現状と今後の展望」
  • Invited
• [Presentation] 医療の未来を拓くために必要なAI技術 (2021)
  • Author(s): 宮野 悟
  • Organizer: 第158回日本医学会シンポジウム
  • Invited
• [Presentation] メディカルデータサイエンスの現状 (2021)
  • Author(s): 宮野 悟
  • Organizer: 第110回日本病理学会総会. 特別企画
  • Invited
• [Presentation] 人工知能と大規模データ解析で変わるがんゲノム研究と医療 (2021)
  • Author(s): 宮野 悟
  • Organizer: 第３９回日本脳腫瘍学会
  • Invited
• [Presentation] スーパーコンピュータを用いた医療とテクノロジーの統合 (2021)
  • Author(s): 宮野 悟
  • Organizer: 第6回医療と創造性及び世界平和シンポジウム
  • Invited
• [Presentation] AIで支援する臨床ゲノム解析 (2021)
  • Author(s): 宮野 悟
  • Organizer: 日本がん分子標的治療学会TRワークショップ
  • Invited
• [Presentation] がん研究・医療とAIに関わる進捗と課題 (2021)
  • Author(s): 宮野 悟
  • Organizer: 第17回日本婦人科がん会議
  • Invited
• [Presentation] Digesting Cancer Big Networks by Explainable AI and Supercomputers (2021)
  • Author(s): Satoru Miyano
  • Organizer: The 3rd R-CCS International Symposium
  • Int'l Joint Research / Invited
• [Presentation] AIでがんのゲノム医療はどこまで的確にかつ効率的になるのか (2021)
  • Author(s): 宮野 悟
  • Organizer: 第85回日本循環器学会_第三回医療AIコンテスト
  • Invited
• [Presentation] Cancer Big Data Challenges from Genomes to Networks (2020)
  • Author(s): Satoru Miyano
  • Organizer: The 24th International Conference on Research in Computational Molecular Biology
  • Int'l Joint Research / Invited
• [Presentation] がん研究・医療のための自然言語処理と説明可能 AI (2020)
  • Author(s): 宮野 悟
  • Organizer: 第79回日本癌学会学術集会
  • Int'l Joint Research / Invited
• [Presentation] On the origin of cancer (2020)
  • Author(s): Seishi Ogawa
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Lung cancer biology: from genomes to function (2020)
  • Author(s): Matthew Meyerson
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Divergent lncRNA MYMLR regulates MYC by eliciting DNA looping and promoter-enhancer interaction (2020)
  • Author(s): Takashi Takahashi
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Mathematical modeling of metabolism in cancer and physical constraints for cell growth (2020)
  • Author(s): Edda Klipp
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Deep Hidden Physics Modeling of Cell Signaling Networks (2020)
  • Author(s): Rune Linding
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Exploring the genetics of population diversity to study hematological trait variation and diseases (2020)
  • Author(s): Guillaume Lettre
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Statistical genetics, disease biology, and drug discovery (2020)
  • Author(s): Yukinori Okada
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Systems Precision Medicine for Tailoring Treatments to Patients with Acute Myeloid Leukemia (2020)
  • Author(s): Olli Kallioniemi
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] MicroRNA Therapeutics in Precision Cancer Medicine (PCM) (2020)
  • Author(s): Johji Inazawa
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Ethics of Cancer Genomics and Discrimination in East Asia: South Korean Experience and Beyond (2020)
  • Author(s): Ock-Joo Kim, Yoon-Jung Chang
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] What Public Concerns Exist Regarding Cancer Genomic Medicine? The Japanese Experience and Beyond (2020)
  • Author(s): Kaori Muto, Akiko Nagai
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Integrative Nutriomics Approach for understanding Cancer and Metabolism (2020)
  • Author(s): Tsuyoshi Osawa
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Cancer Big Data Challenges by Supercomputers and Artificial Intelligence (2020)
  • Author(s): Satoru Miyano
  • Organizer: International Conference on Cancer Systems Biology Beyond
  • Int'l Joint Research / Invited
• [Presentation] Cancer Big Data Analysis with Supercomputers (2019)
  • Author(s): Satoru Miyano
  • Organizer: The 2nd Workshop “PRACTICES IN BIOINFORMATICS AND SYSTEMS BIOLOGY”
  • Int'l Joint Research / Invited
• [Presentation] Genomon: A cancer genome mutation detection pipeline (2019)
  • Author(s): Kotoe Katayama
  • Organizer: The 2nd Workshop “PRACTICES IN BIOINFORMATICS AND SYSTEMS BIOLOGY”
  • Int'l Joint Research / Invited
• [Presentation] Computational Prediction of Gene Networks for Drug Target Discovery (2019)
  • Author(s): Seiya Imoto
  • Organizer: The 2nd Workshop “PRACTICES IN BIOINFORMATICS AND SYSTEMS BIOLOGY”
  • Int'l Joint Research / Invited
• [Presentation] Nanopore sequencing: from basecalling to structural variant detection (2019)
  • Author(s): Yaozhong Zhang
  • Organizer: The 2nd Workshop “PRACTICES IN BIOINFORMATICS AND SYSTEMS BIOLOGY”
  • Int'l Joint Research / Invited
• [Presentation] Flexible Bayesian Modeling for Accurate Mutation Calling from Multi-Regional Tumors (2019)
  • Author(s): Takuya Moriyama
  • Organizer: The 2nd Workshop “PRACTICES IN BIOINFORMATICS AND SYSTEMS BIOLOGY”
  • Int'l Joint Research / Invited
• [Presentation] Accelerating Cancer Clinical Sequence by Artificial Intelligence and Supercomputer (2018)
  • Author(s): 宮野 悟
  • Organizer: Seminar Precision Medicine in the 21st Century in Mexico
  • Int'l Joint Research / Invited
• [Remarks] システム癌新次元ホームページ
  • URL: http://neosystemscancer.hgc.jp/home
• [Remarks] システム癌新次元ホームページ
  • URL: http://neosystemscancer.hgc.jp/
• [Remarks] システム癌新次元ホームページ
  • URL: http://neosystemscancer.hgc.jp/csbbeyond
• [Remarks] 国際会議"Cancer Systems Biology Beyond"ホームページ
  • URL: http://neosystemscancer.hgc.jp/csbbeyond
• [Remarks] 国際会議"ISPCM2020"ホームページ
  • URL: https://www2.aeplan.co.jp/ispcm2020/index.html
• [Remarks]
  • URL: http://neosystemscancer.hgc.jp/home
• [Remarks] 新学術領域「システム癌新次元」
  • URL: http://neosystemscancer.hgc.jp/
• [Funded Workshop] International Conference on Cancer Systems Biology Beyond (2020)
• [Funded Workshop] II WORKSHOP “PRACTICES IN BIOINFORMATICS AND SYSTEMS BIOLOGY” (2019)
• [Funded Workshop] Joint Hong Kong-Japan Bioinformatics and Systems Biology Workshop (2018)
• [Funded Workshop] The Workshop on Bioinformatics at the Supercomputing Facility of Cinvestav (2018)
• [Funded Workshop] Precision Medicine in the 21st Century, El Colegio Nacional Mexico (2018)